A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

Clinical trial NCT01449058 · COMPLETED

Trial details

NCT number: NCT01449058
Sponsor: Array BioPharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced and Selected Solid Tumors AML High Risk and Very High Risk MDS

Start date: 2012-03-01
Primary completion: 2016-08-31
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.